Research Topics
| Jeff M MichalskiSummaryAffiliation: Washington University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406Jeff Michalski
Department of Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 83:e363-70. 2012..Report of clinical cancer control outcomes on Radiation Therapy Oncology Group (RTOG) 9406, a three-dimensional conformal radiation therapy (3D-CRT) dose escalation trial for localized adenocarcinoma of the prostate...- Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 76:361-8. 2010..To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer... - Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation studyJeff M Michalski
Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 76:14-22. 2010..To update the incidence of late toxicity of RTOG 9406, a three-dimensional conformal radiation therapy (3DCRT) dose escalation trial for prostate cancer... - Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117Jeffrey D Bradley
Department of Radiation Oncology, Washington University School of Medicine, Alvin J Siteman Comprehensive Cancer Center, 4921 Parkview Place, St Louis, MO, USA
J Clin Oncol 28:2475-80. 2010..The radiation dose was 74 Gy given in 37 fractions. Radiation therapy volumes included those of the gross tumor and involved nodes. The volume of lung at or exceeding 20 Gy (V20) was mandated to be <or= 30%... 
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failureMichael E Ray
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
Urology 68:1257-62. 2006..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...- Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIJeff M Michalski
Department of Radiation Oncology, Washington University, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 56:192-8. 2003..To evaluate the rates of low-grade late effects in patients treated for prostate cancer on Radiation Therapy Oncology Group (RTOG) 9406... - PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 64:1140-50. 2006.... 
Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapyJesse N Aronowitz
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA
Am J Clin Oncol 33:164-7. 2010..To determine whether there is an optimal type of mathematical equation for predicting seed and activity requirements for permanent prostate brachytherapy...- Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an updateCarlos A Perez
Department of Radiation Oncology, Washington University Medical Center, St Louis, MO, USA
Clin Prostate Cancer 1:97-104. 2002..Follow-up at > or = 10 years is needed to confirm these observations... - Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IVJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
Int J Radiat Oncol Biol Phys 58:735-42. 2004..This is the first report of the toxicity outcomes using dose level IV (74 Gy) on Radiation Therapy Oncology Group (RTOG) study 9406 for Stage T1-T2 prostate adenocarcinoma... - Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapyJeffrey R Olsen
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Radiother Oncol 104:199-204. 2012..Dose effects of intrafraction motion during prone prostate radiotherapy are unknown. We compared prone and supine treatment using real-time tracking data to model dose coverage... - Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level VJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 62:706-13. 2005..This is the first report of toxicity outcomes at dose Level V (78 Gy) on Radiation Therapy Oncology Group 9406 for Stages T1-T2 adenocarcinoma of the prostate... - Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406Jeff M Michalski
Washington University Medical School, St Louis, MO 63110, USA
Semin Radiat Oncol 12:75-80. 2002..Clinical trials should use quality-of-life measures to determine that trade-offs between severity and rates of toxicity are acceptable to patients... - Long-term outcome in children treated for craniopharyngioma with and without radiotherapyLilie L Lin
Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Neurosurg Pediatr 1:126-30. 2008..The authors report the results of surgery alone or in combination with radiotherapy in the management of craniopharyngiomas in children... - Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 68:1417-23. 2007..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities... - Glioblastoma in children: a single-institution experienceStephanie M Perkins
Department of Radiation Oncology and Mallinkrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
Int J Radiat Oncol Biol Phys 80:1117-21. 2011..However, even with this multispecialty approach, overall survival remains poor. To assess outcome and evaluate treatment-related prognostic factors, we retrospectively reviewed the experience at our institution... - Uncertainties in radiation therapy: target volume definition in prostate cancerCarlos A Perez
Department of Radiation Oncology, Washington University Medical Center, St. Louis, MO 63108, USA
Rays 28:267-88. 2003..Multiple imaging methods are available and significant advances have been made in image fusion to enhance target volume definition. An exhaustive review of the literature is presented... - Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapyMingyao Zhu
Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 85:1038-44. 2013.... - Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlasHiram A Gay
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110 6311, USA
Int J Radiat Oncol Biol Phys 83:e353-62. 2012..To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials... - Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)Janice K Ryu
Department of Radiation Oncology, University of California at Davis, 4501 X Street, Suite G126, Sacramento, CA 95817, USA
Int J Radiat Oncol Biol Phys 54:1036-46. 2002..This is a preliminary report of toxicity at Level III (79.2 Gy) on 3D Oncology Group/Radiation Therapy Oncology Group (RTOG) 9406... - A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117Jeffrey D Bradley
Washington University School of Medicine, St Louis, Missouri, USA
Int J Radiat Oncol Biol Phys 77:367-72. 2010.... - Positron tomographic assessment of androgen receptors in prostatic carcinomaFarrokh Dehdashti
The Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, 63110, USA
Eur J Nucl Med Mol Imaging 32:344-50. 2005.... - Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:915-28. 2003..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era... - Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic trackingJeffrey R Olsen
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
Int J Radiat Oncol Biol Phys 82:1903-11. 2012..We present an analysis of PTV adequacy and a proposed adaptive process... - Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomyCarlos A Perez
Department of Radiation Oncology, Mallinckrodt, Institute of Radiology, St Louis, MO 63108, USA
Clin Prostate Cancer 1:235-41. 2003..Prostate bed irradiation is an effective treatment in a significant proportion of patients who present with a biochemical failure after radical prostatectomy... - Inter-institutional variation of implant activity for permanent prostate brachytherapyJesse N Aronowitz
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 01605, USA
Brachytherapy 7:297-300. 2008..Despite the existence of guidelines for permanent prostate brachytherapy, it is unclear whether there is interinstitutional consensus concerning the parameters of an ideal implant... - Radiation dose-volume effects in radiation-induced rectal injuryJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 76:S123-9. 2010..It is possible that intensity-modulated radiotherapy or proton beam dose distributions require modification of these models because of the inherent differences in low and intermediate dose distributions... - Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03Christina Tsien
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Int J Radiat Oncol Biol Phys 73:699-708. 2009..To evaluate in a Phase I trial the feasibility and toxicity of dose-escalated three-dimensional conformal radiotherapy (3D-CRT) concurrent with chemotherapy in patients with primary supratentorial glioblastoma (GBM)... - Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparisonMalika L Siker
Department of Radiation Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
J Neurooncol 104:351-6. 2011..1-3.6% of our patients. They have superior survival, even when adjusted for RPA class. More investigations on the unique biologic and clinical characteristics of tumors in this population are needed... - Long term outcome with post-operative radiation therapy for spinal canal ependymomaSasha H Wahab
Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
J Neurooncol 83:85-9. 2007..A retrospective study was performed to evaluate the long term efficacy and safety of post-operative radiation therapy in the management of spinal canal ependymoma at our institution... - Predicting dose-volume histograms for organs-at-risk in IMRT planningLindsey M Appenzoller
Department of Radiation Oncology, Washington University, St Louis, MO, USA
Med Phys 39:7446-61. 2012.... - Oligodendrogliomas in childrenKimberly M Creach
Department of Radiation Oncology and Mallinckrodt Institute of Radiology, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO 63110, USA
J Neurooncol 106:377-82. 2012..Our data demonstrate that patients with less than GTR and <3 years at diagnosis are at increased risk for progression and may benefit from more aggressive therapy... - Postoperative radiation therapy for grade II and III intracranial ependymomaDavid B Mansur
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 61:387-91. 2005..To retrospectively determine the long-term outcome of intracranial ependymoma patients treated with surgery and postoperative radiation therapy... - Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemiaDavid B Wilson
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Pediatr Hematol Oncol 25:910-3. 2003..By manipulating the GVL effect it is possible to achieve a prolonged bone marrow remission, but only at the expense of unmasking the risk of late extramedullary relapse... - A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessmentReshma Jagsi
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
Int J Radiat Oncol Biol Phys 84:318-22. 2012..The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care... - 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapseNobuyuki Oyama
Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Boulevard, St. Louis, MO 63110, USA
J Nucl Med 44:549-55. 2003..CONCLUSION: AC PET demonstrates marked uptake in prostate cancer and has higher sensitivity than (18)F-FDG PET. These preliminary data show that (11)C-acetate is a promising tracer for detection of recurrent prostate cancer... - Dose escalation in locally advanced carcinoma of the prostateAngel I Blanco
Department of Radiation Oncology, Washington University, St Louis, MO, USA
Semin Radiat Oncol 13:87-97. 2003..A confirmatory trial within the Radiation Therapy Oncology Group is underway to determine if dose escalation will improve overall survival in men without compromising quality of life... - Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Brachytherapy 6:2-8. 2007..This study is aimed at understanding and defining the current patterns of care with respect to prostate brachytherapy for patients with intermediate-risk localized disease in the combined academic and community setting... - Radiation therapy in the management of locally advanced prostate cancerJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, Campus Box 8224, 4921 Parkview Place, St Louis, MO 63110, USA
Curr Urol Rep 7:217-24. 2006.... - Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen eraAdam S Kibel
Division of Urology, Department of Surgery, Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri, USA
J Urol 187:1259-65. 2012..However, it is unknown if survival differences exist among treatments. We analyzed the survival of patients treated with these modalities according to contemporary standards... - Method to plan, administer, and verify supine craniospinal irradiationJeff M Michalski
Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Appl Clin Med Phys 3:310-6. 2002..The supine patient position does not present any difficulties in field matching or verification... - Childhood and adolescent thyroid carcinomaPerry W Grigsby
Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, Missouri 63110, USA
Cancer 95:724-9. 2002..This analysis was performed to evaluate the influence of clinical and treatment factors on local tumor control, control of distant metastasis, survival, and complications in children and adolescents with thyroid carcinoma... - Event (error and near-miss) reporting and learning system for process improvement in radiation oncologySasa Mutic
Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, St Louis, Missouri 63110, USA
Med Phys 37:5027-36. 2010..The purpose of this work is to report on the design and long-term use of an electronic reporting system in a RT department and compare it to the paper-based reporting system it replaced... - Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVJeff M Michalski
Department of Radiation Oncology, Washington University School of Medicine, Box 8224, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 59:1027-38. 2004....